Axinn Promotes Stacie Ropka and Jeny Maier
January 1, 2017
Stacie Ropka was promoted to Partner in the Intellectual Property Group. With a PhD in Microbiology and Immunology, her practice focuses on intellectual property litigation, due diligence and client counseling, with an emphasis on the life sciences, biologics and biologic-based pharmaceuticals. Stacie’s IP counseling and due diligence experience includes extensive counseling for product development efforts relating to biologics and reconstructive biomaterials, including monoclonal antibodies and products that utilize adult stem cells. In addition, she also serves on trial teams for patent lawsuits involving major pharmaceutical companies.
Jeny Maier was promoted to Counsel in the Antitrust Group. Her practice focuses on advising parties to M&A transactions on domestic and international pre-merger notification requirements and substantive antitrust issues, as well as assisting clients with responding to civil and criminal antitrust investigations, and defending related class-action litigation. Jeny advises clients on antitrust issues relating to pricing practices, distribution and marketing arrangements, intellectual property license agreements, and standard setting activities. She works with clients across a broad range of industries, with particular experience in the technology, telecommunications, transportation, health care and pharmaceutical fields.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property
Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
Deals & Cases
Antitrust
Recent Benchmarking Suits Highlight DOJ Enforcement Risks
Byline Articles
Antitrust
“Old Crime, New Code” – DOJ Outlines its Views on When Software and AI Can Facilitate Collusion
Axinn Viewpoints
Antitrust
